Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
Discover how the FDA-approved Invitae’s Common Hereditary Cancers Panel can enhance your approach to early cancer detection and personalized treatment planning.
Hematology/Oncology October 9th 2023
The New England Journal of Medicine
Explore the intricate relationship between stem cell self-renewal and precancer states to better understand its implications for future cancer therapies
Explore the complexities of prostate cancer treatment options through a detailed case study that weighs the benefits and risks of radical treatment versus active surveillance.
Oncology, Medical October 9th 2023
Cancer Therapy Advisor
Discover how pre-surgery treatment with T-VEC can significantly improve long-term survival rates in advanced melanoma patients, as revealed in a recent phase 2 trial.
Dermatology October 2nd 2023
Renal & Urology News
Discover the key predictors of PSA persistence post-prostate cancer surgery and how they can inform your treatment plans and patient discussions.
Oncology, Medical October 2nd 2023
MDLinx
Discover how mechanoresilient cancer cells evade the body’s natural defenses and what this means for the future of targeted cancer therapies.
Hematology/Oncology October 2nd 2023